Opticyte

Private

Seattle, WashingtonHealthcare & Life Scienceshttps://www.opticyte.com/

Last Round

Convertible Debt

Dec 5, 2024

Total Funding Raised

$5.7M

Company Overview

Opticyte is a medical device company that develops noninvasive technology for real-time monitoring of cellular oxygenation to aid in the early detection and prevention of organ failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

tissue oximeternear-infrared spectroscopyNIRSmedical devicepatient monitoringtissue oxygenationcritical care monitoringnon-invasive monitoringclinical monitoringmedtechhemodynamic monitoringoptical sensorbedside monitorsurgical monitoringhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Opticyte Comps

Public and private peers based on sector, stage, and business model.

Opticyte comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Opticyte Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Convertible Debt	Dec 5, 2024
Crowdfunding	Oct 31, 2024
Seed	Nov 1, 2020
Grant	May 1, 2020

View all Funding Rounds

Opticyte Investors

Notable investors and investment history

Opticyte investors
Investor	Rounds
NIH RADx	Grant
FBomb Angels	Convertible Debt

View all Investors

Opticyte Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Opticyte Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Opticyte's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington

Employee Range9

Year Founded2016

Last FundingDec 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.